KONT 📈 Kontigo Care AB - Overview

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0007075247

KONT: Alcohol, Addiction, Gambling, Drugs, Mental, Family, Workplace

Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Alcohol, a digital medical device for the treatment of alcohol addiction; Previct Gamble, a digital tool for the treatment of gambling addiction; Previct Drugs, a digital platform to stop drug addiction; Previct Mind, a modern tool used as support in the treatment of mental illness; Previct Family, a tool for the whole family when the whole family is in contact with a therapist for family's well-being; Previct Work, a digital supports that are used in addiction care at the workplace. The company was incorporated in 2013 and is based in Uppsala, Sweden. Web URL: https://www.kontigocare.com

Additional Sources for KONT Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

KONT Stock Overview

Market Cap in USD 9m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception

KONT Stock Ratings

Growth 5y -35.7%
Fundamental 17.7%
Dividend -
Rel. Strength Industry -210
Analysts -
Fair Price Momentum 2.42 SEK
Fair Price DCF -

KONT Dividends

No Dividends Paid

KONT Growth Ratios

Growth Correlation 3m 47.1%
Growth Correlation 12m 37.5%
Growth Correlation 5y -58.1%
CAGR 5y -8.02%
CAGR/Mean DD 5y -0.24
Sharpe Ratio 12m 0.35
Alpha -0.24
Beta 0.11
Volatility 67.20%
Current Volume 19.5k
Average Volume 20d 37.5k
What is the price of KONT stocks?
As of December 22, 2024, the stock is trading at SEK 2.76 with a total of 19,530 shares traded.
Over the past week, the price has changed by -8.28%, over one month by -0.75%, over three months by +2.31% and over the past year by -2.56%.
Is Kontigo Care AB a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Kontigo Care AB is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.70 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KONT as of December 2024 is 2.42. This means that KONT is currently overvalued and has a potential downside of -12.32%.
Is KONT a buy, sell or hold?
Kontigo Care AB has no consensus analysts rating.
What are the forecast for KONT stock price target?
According to ValueRays Forecast Model, KONT Kontigo Care AB will be worth about 2.6 in December 2025. The stock is currently trading at 2.76. This means that the stock has a potential downside of -5.43%.
Issuer Forecast Upside
Wallstreet Target Price 5.4 95.7%
Analysts Target Price - -
ValueRay Target Price 2.6 -5.4%